[go: up one dir, main page]

AU2252297A - Method of diagnosis and treatment and related compositions and apparatus - Google Patents

Method of diagnosis and treatment and related compositions and apparatus

Info

Publication number
AU2252297A
AU2252297A AU22522/97A AU2252297A AU2252297A AU 2252297 A AU2252297 A AU 2252297A AU 22522/97 A AU22522/97 A AU 22522/97A AU 2252297 A AU2252297 A AU 2252297A AU 2252297 A AU2252297 A AU 2252297A
Authority
AU
Australia
Prior art keywords
diagnosis
treatment
related compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22522/97A
Inventor
William M. Hammesfahr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technology Licensing Co LLC
Original Assignee
Technology Licensing Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technology Licensing Co LLC filed Critical Technology Licensing Co LLC
Publication of AU2252297A publication Critical patent/AU2252297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
    • A61B8/08—Clinical applications
    • A61B8/0808—Clinical applications for diagnosis of the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU22522/97A 1996-01-31 1997-01-29 Method of diagnosis and treatment and related compositions and apparatus Abandoned AU2252297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1088196P 1996-01-31 1996-01-31
US010881 1996-01-31
PCT/US1997/001576 WO1997027745A1 (en) 1996-01-31 1997-01-29 Method of diagnosis and treatment and related compositions and apparatus

Publications (1)

Publication Number Publication Date
AU2252297A true AU2252297A (en) 1997-08-22

Family

ID=21747861

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22522/97A Abandoned AU2252297A (en) 1996-01-31 1997-01-29 Method of diagnosis and treatment and related compositions and apparatus

Country Status (2)

Country Link
AU (1) AU2252297A (en)
WO (1) WO1997027745A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903028D0 (en) * 1999-08-27 1999-08-27 Astra Ab New use
PL353199A1 (en) 1999-08-30 2003-11-03 Aventis Pharma Deutschland Gmbh Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
IL149106A0 (en) * 2001-04-20 2002-11-10 Pfizer Prod Inc Therapeutic use of selective pde10 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163790A (en) * 1977-05-11 1979-08-07 A. H. Robins Company, Inc. Method for increasing coronary blood flow in mammals
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition

Also Published As

Publication number Publication date
WO1997027745A1 (en) 1997-08-07

Similar Documents

Publication Publication Date Title
AU4826097A (en) Method and apparatus for diagnosis and treatment of arrhythmias
AU5530098A (en) Method and apparatus for diagnosis and treatment of arrhythmias
AU5604298A (en) Method and apparatus for diagnosis and treatment of arrhythmias
AU3056397A (en) Prioritized rule based method and apparatus for diagnosis and treatment of arrhythmias
AU2103195A (en) Device and method for treatment of dentition
AU2277595A (en) Device and method for treatment of skin
AU3077497A (en) Method and apparatus for treatment of air way obstructions
AU3552195A (en) Improved patient-transport and treatment apparatus
AU4838097A (en) Apparatus for the treatment of specimens
AU5439996A (en) Compositions and methods for treating pain
AU1136297A (en) Methods and compositions for diagnosis of hyperhomocysteinemia
AUPP028497A0 (en) Improved apparatus and method for micro-abrasions of human tissues and/or hides
AU2547497A (en) Apparatus and method for sterilization of instruments
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU1572897A (en) Apparatus and method for the diagnosis of true labor
AU2225195A (en) Method for treatment of residues from organochlorosilane and/or chlorosilansynthesis
GB9509897D0 (en) Apparatus for and method of condition diagnosis
AU1340697A (en) Bunion treatment apparatus and method
AU7395096A (en) Method for facilitating dental diagnosis and treatment
AU1714697A (en) Method and composition for the treatment of osteoarthritis
AU3768795A (en) Method and compositions for hair treatment
AU6165898A (en) Method and apparatus for the treatment of strabismus
AU7486898A (en) Global medical treatment method and apparatus
AU2252297A (en) Method of diagnosis and treatment and related compositions and apparatus
AU4027097A (en) Method of treatment